Zacks.com on MSN3mon
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?
Merck has a Zacks Rank #3 (Hold) stock currently. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks ...
Business Wire1mon
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE ... discontinued after cycle 1 due to physician decision and was entered to safety follow-up, or 2.25 mg/kg (n=6); 5 patients in this arm completed ...
MarketWatch8d
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors
Shares of Merck & Co. Inc. MRK slid 1.72% to $96.24 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.88% to 6,049.24 ...